|
|
|
| This article has been cited by | | 1 | Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy | | | Timothy M. Pierpont,Candice B. Limper,Kristy L. Richards | | Frontiers in Oncology.2018;8() | | [DOI] | | | 2 | Similar biologics in India: A story of access or potential for compromise? | | | Ramesh Jois,Sukumar Mukherjee,S Rajeswari,PD Rath,Vishal Goyal,Disha Gupta | | Indian Journal of Medical Research.2020;152(5)456 | | [DOI] | |
|
